The Federal Trade Commission has rescinded a Biden-era policy statement that had expanded expectations around breach notifications for certain health apps and connected-device providers. The move is part of a broader agency push toward regulatory streamlining, but it also sends a clear signal to the digital-health market: the FTC may be narrowing how aggressively it interprets and enforces health-data breach obligations outside traditional healthcare settings.

At issue is the FTC’s approach to the Health Breach Notification Rule, which applies to certain vendors of personal health records and related entities not covered by HIPAA.

A new inter partes review, IPR2026-00391, was filed on June 5, 2026, at the Patent Trial and Appeal Board naming Teladoc Health, Inc. in the proceeding. The filing places another spotlight on the digital health and telemedicine patent landscape, where platform functionality, remote care workflows, and software-driven healthcare delivery continue to generate high-stakes validity disputes.

At this early stage, the PTAB docket identifies the proceeding by title but may not yet reflect the full set of publicly available petition details practitioners typically watch for, including the specific patent number, the complete alignment of petitioner and patent owner, and the precise prior-art combinations asserted in the challenge.